Photobiomodulation (PBM) enhances the survival of nigral dopaminergic cells in a chronic MPTP mouse model of Parkinson’s disease

Previous PostMolecular hydrogen as an emerging therapeutic medical gas for neurodegenerative and other diseases
Next PostNear-infrared light therapy alleviates Alzheimer's disease-related pathology in two transgenic mouse models – evidence from the cerebral cortex

Disclaimer: The medical papers and academic information provided on this site are intended for educational purposes only and are not meant to diagnose, treat, prevent diseases, or substitute for a doctor’s advice.

Photobiomodulation (PBM) enhances the survival of nigral dopaminergic cells in a chronic MPTP mouse model of Parkinson’s disease

Previous PostMolecular hydrogen as an emerging therapeutic medical gas for neurodegenerative and other diseases

Next PostNear-infrared light therapy alleviates Alzheimer's disease-related pathology in two transgenic mouse models – evidence from the cerebral cortex

Photobiomodulation Treatment device

Hyperbaric Oxygen Chamber

Other Products

About

Learn More

Product Background

References

Get In Touch

Hyperbaric Oxygen
Chamber